Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
04/21/2023	12:01AM	PR Newswire (US)	AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA®) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting	NYSE:ABBV	AbbVie Inc
04/19/2023	5:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/18/2023	10:04AM	PR Newswire (US)	Allergan Aesthetics Celebrates the Journeys of Women Surgeons with LIMITLESS	NYSE:ABBV	AbbVie Inc
04/17/2023	7:41PM	PR Newswire (US)	U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine	NYSE:ABBV	AbbVie Inc
04/17/2023	5:44PM	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NYSE:ABBV	AbbVie Inc
04/17/2023	8:01AM	PR Newswire (Canada)	AbbVie Announces Provincial Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia in Québec	NYSE:ABBV	AbbVie Inc
04/17/2023	8:01AM	PR Newswire (Canada)	AbbVie annonce le remboursement provincial, au Québec, de VRAYLAR® (cariprazine) pour le traitement de la schizophrénie	NYSE:ABBV	AbbVie Inc
04/17/2023	2:00AM	PR Newswire (US)	AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease	NYSE:ABBV	AbbVie Inc
04/12/2023	11:00AM	PR Newswire (US)	AbbVie Invites College Students Living with Cystic Fibrosis to Apply for the AbbVie CF Scholarship for the 2023-2024 Academic School Year	NYSE:ABBV	AbbVie Inc
04/11/2023	12:35PM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
04/05/2023	5:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/05/2023	5:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/05/2023	4:34PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/04/2023	8:00AM	PR Newswire (US)	AbbVie to Host First-Quarter 2023 Earnings Conference Call	NYSE:ABBV	AbbVie Inc
04/03/2023	8:00AM	PR Newswire (US)	CoolSculpting® Elite Announces First Ever CoolMonth	NYSE:ABBV	AbbVie Inc
03/29/2023	9:00AM	PR Newswire (US)	Allergan Aesthetics* to showcase 360° approach to clinical practice, aesthetic products, and patients with expert-led symposia at AMWC 2023	NYSE:ABBV	AbbVie Inc
03/28/2023	4:40PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
03/28/2023	6:02AM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
03/23/2023	9:26AM	Dow Jones News	AbbVie's Skyrizi Hits Goals in Ulcerative Colitis Study	NYSE:ABBV	AbbVie Inc
03/23/2023	9:00AM	PR Newswire (US)	AbbVie Advances Upadacitinib (RINVOQ®) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus	NYSE:ABBV	AbbVie Inc
03/23/2023	8:30AM	PR Newswire (US)	Risankizumab (SKYRIZI®) Achieves Primary and All Secondary Endpoints in Phase 3 Induction Study in Patients With Ulcerative Colitis	NYSE:ABBV	AbbVie Inc
03/22/2023	9:44AM	Dow Jones News	FDA Rejects AbbVie Parkinson's Treatment; Seeks More Data	NYSE:ABBV	AbbVie Inc
03/22/2023	8:45AM	PR Newswire (US)	AbbVie Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New Drug Application	NYSE:ABBV	AbbVie Inc
03/21/2023	5:23PM	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NYSE:ABBV	AbbVie Inc
03/20/2023	5:01PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NYSE:ABBV	AbbVie Inc
03/18/2023	10:03AM	PR Newswire (US)	AbbVie Announces Late-Breaking Results of Study Evaluating 52-Week Efficacy and Safety of SKYRIZI® (risankizumab) in Plaque Psoriasis Patients With a Prior Suboptimal Response to IL-17 Inhibitor Therapy	NYSE:ABBV	AbbVie Inc
03/15/2023	5:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/15/2023	8:03AM	PR Newswire (US)	AbbVie Partners with Award-Winning Redglass Pictures on New Film Shedding Light on the Hidden Struggles of Those Living with Eczema	NYSE:ABBV	AbbVie Inc
03/13/2023	8:03AM	PR Newswire (US)	AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting	NYSE:ABBV	AbbVie Inc
03/08/2023	8:45AM	PR Newswire (US)	BOTOX® Cosmetic (onabotulinumtoxinA) Partners with IFundWomen to Help Close the Confidence Gap for Women Entrepreneurs	NYSE:ABBV	AbbVie Inc